Platelet activating factor: Release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretion

Gut

Volumn 38, Issue 3, 1996, Pages 355-361

  Wardle, T D ^a,b   Hall, L ^a   Turnberg, L A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Countess of Chester Hospital ^*  (United Kingdom)

Author keywords

Arachidonic acid; Cyclooxygenase; Eicosanoid; Leukotriene D4; Lipoxygenase; Phospholipase A2; Platelet activating factor; Prostaglandin E2

Indexed keywords

2 (3 PYRIDYLMETHYL)INDAZOLINONE; 2 [N (2 METHOXY 3 OCTADECYLCARBAMOYLOXYPROPOXYCARBONYL)ACETAMIDOMETHYL] 1 ETHYLPYRIDINIUM CHLORIDE; ARACHIDONIC ACID; BRADYKININ; CHLORPHENIRAMINE; HISTAMINE; HYDROCORTISONE; ICOSANOID; INDOMETACIN; LEUKOTRIENE D4; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; MEPACRINE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; BIOPSY; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0029960010     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.3.355     Document Type: Article

References (25)

1. Benveniste J, Henson PM, Cochrane CG. Leukocyte dependent histamine release from rabbit platelets. The Role for IgE, basophils and a platelet activating factor. J Exp Med 1972; 136: 1356-77.
2. Albert DH, Snyder F. Biosynthesis of 1-alkyl-1-acetyl-sn-glycero-3-phosphocholine (PAF) from 1-alkyl-2-acyl-sn-glycero-3-phosphocoline by rat alveolar macrophages. J Biol Chem 1983; 25: 97-102.
3. Sanchez-Crespo M, Alonson F, Edigo J. PAF in anaphylaxes and phagocytosis. Immunology 1980; 40: 645-55.
4. Chignard M, Le Couedic JP, Tence M, Benveniste J. The role of PAF in platelet aggregation. Nature 1979; 279: 799-800.
5. Eliakim R, Karmeli F, Razin E, Rachmilewitz D. Role of platelet activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology 1979; 95: 1167-72.
6. Hwant SB, Lam MH. Ionic and GTP regulation of binding of PAF to receptors and PAF induced activation of GTPase in rabbit platelet membranes. J Biol Chem 1986; 261: 532-7.
7. Valone FG, Goetzl EJ. Specific binding by human polymorphonuclear leucocytes of the immunological mediator. Immunology 1982; 48: 141-8.
8. Doebber JW, Wu MS, Shen TY. Platelet activating factor (PAF) intravenous infusion in rat stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils. Biochem Biophys Res Commun 1984; 125: 980-7.
9. Humphrey DM, McManus LM, Satouchi K, Hanahan DJ, Pinckard RB. Vasoactive properties of acetyl glyceryl ether phosphorycholine and analogues. Lab Invest 1982; 46: 422-7.
10. McManus LM, Hanahan DJ, Demopoulos CA, Pinckard RN. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorycholine (AGEPG), a synthetic platelet activating factor (PAF) in the rabbit. J Immunol 1980; 124: 2919-24.
11. Poitenin B, Mencia-Heurta JM, Roubin R, Benveniste J. Role of PAF acether in neutrophil activation. In: Said SL. The pulmonary circulation and acute lung injury. Mount Kisco, NY: Future Publishing, 1985: 357-73.
12. Lapetina EG. Platelet activating factor stimulates the phosphatidyl inositol cycle. J Biol Chem 1982; 257: 7314-7.
13. Bern MJ, Sturbaum CN, Karayalcin SS, Berschneider HM, Wachsman JT, Powell DW. Immune system control of rat and rabbit colonie electrolyte transport. J Clin Invest 1989; 83: 1810-20.
14. Wardle TD, Hall L, Turnberg LA. Interrelationships between inflammatory mediators released from colonic mucosa in ulcerative colitis, and their effects on colonic secretion. Gut 1993; 34: 503-8.
15. Wardle TD, Hall L, Turnberg LA. Use of co-culture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut 1992; 33: 1644-51.
16. 2 in plasma and tissue samples. Stevenage, Herts: New Research (Du Pont de Nemours), 1988.
17. 4 assay system. Aylesbury, Bucks: Amersham International PLC, 1988.
18. Ussing HH, Zerahn K. Active transport of sodium as a source of electric current in the short circuited isolated frog skin. Acta Physiol Scand 1951; 23: 110-27.
19. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames, Iowa: Iowa State University, 1980.
20. 4 synthesis in human polymorphonuclear leukocytes. J Clin Invest 1982; 70: 1058-62.
21. 4 mediated neutrophil chemotaxis through an intact endothelial cell monolayer. Biochim Biophys Acta 1984; 805: 30-6.
22. O'Flaherty JT, Thomas MJ, Hammett MJ, Carroll C, McCall CE, Wykle RL. 5 L-hydroxy-6,8,11,14 eicosate-tranoate potentiates the human neutrophil degranulating action of platelet activating factor. Biochim Biophys Res Commun 1983; 111: 1-7.
23. Hawkey CJ, Rampton DS. Prostaglandins in the gastrointestinal mucosa, are they important in its function, disease or treatment? Gastroenterology 1985; 89: 1162-8.
24. Rampton DS, Sladen GE. Relapse of ulcerative proctitis during treatment with non-steroidal anti-inflammatory drugs. Postgrad Med J 1981; 57: 297-9.
25. Rampton DS, Sladen GE. Prostaglandin inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment. Prostaglandins 1987; 21: 417-25.